Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells. (Q39794629)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225866%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225866%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225866%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

3

Yuh-Lih Chang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225866%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

5

Yi-Wei Chen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225866%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

10

Shih-Hwa Chiou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225866%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Han-Shui Hsu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225866%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Ching Tzao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225866%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Hsin-Chin Shih

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225866%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Shih-Chieh Hung

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225866%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Yu-Chih Chen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225866%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Ling-Ming Tseng

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225866%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

English

0 references

publication date

10 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225866%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

number of pages

16

1 reference

inferred from page(s)

published in

Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225866%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225866%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225866%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

2970-2985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225866%20AND%20SRC:MED&resulttype=core&format=json

Multidisciplinary management of lung cancer

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

Limited-stage small-cell lung cancer: the current status of combined-modality therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

Lung cancer: future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

CD133: molecule of the moment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

Identification and characterization of tumorigenic liver cancer stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

Identification and expansion of the tumorigenic lung cancer stem cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

Stat proteins and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

Activation of STAT proteins and growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

Clinical impact of phosphorylated signal transducer and activator of transcription 3, epidermal growth factor receptor, p53, and vascular endothelial growth factor receptor 1 expression in resected adenocarcinoma of lung by using tissue microarray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

Role of Stat3 in regulating p53 expression and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

The STATs of cancer--new molecular targets come of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

Resveratrol-induced apoptosis and increased radiosensitivity in CD133-positive cells derived from atypical teratoid/rhabdoid tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

Augmentation of radiation response by panitumumab in models of upper aerodigestive tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

Cucurbitacin: ancient compound shedding new light on cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

Bcl-XL and STAT3 mediate malignant actions of gamma-irradiation in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

7 January 2021

Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

7 January 2021

Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

7 January 2021

Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25869

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.25869

1 reference

7 January 2021